Atıf İçin Kopyala
Sayin B. Y., Al Mahmeed W., Ragy H. I., Elbahry A., Virdone S., Kakkar A. K., ...Daha Fazla
ADVANCES IN THERAPY, cilt.38, sa.5, ss.2391-2405, 2021 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
38
Sayı:
5
-
Basım Tarihi:
2021
-
Doi Numarası:
10.1007/s12325-021-01670-5
-
Dergi Adı:
ADVANCES IN THERAPY
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus, PASCAL, BIOSIS, Biotechnology Research Abstracts, CAB Abstracts, CINAHL, EMBASE, International Pharmaceutical Abstracts, MEDLINE
-
Sayfa Sayıları:
ss.2391-2405
-
Anahtar Kelimeler:
Antithrombotic treatment, Atrial fibrillation, Oral anticoagulants, Stroke
-
İstanbul Üniversitesi Adresli:
Hayır
Özet
Introduction: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) aims to determine real-life treatment patterns and clinical outcomes of patients with newly diagnosed non-valvular atrial fibrillation (AF) and at least one investigator-determined risk factor for stroke. The registry includes a wide array of baseline characteristics and has a particular focus on: (1) bleeding and thromboembolic events; (2) international normalized ratio fluctuations; and (3) therapy compliance and persistence patterns.